Investigational Site Number 6160006

Poznan 60-823

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise — Completed